Financials
- Fiscal year
- 2025
- Total assets
- €2.7m
- Loss
- -€1.2m
- Solvency
- 17.3%
Total assets▼ 30.8%
Net result
20192025
Medispar
ActiveSummary
The computed 12-month bankruptcy probability of Medispar is 1.9% (moderate). The annual accounts of Medispar for fiscal year 2025 show a net loss of 498% of the equity at the start of that year. The 2025 annual accounts show equity of €471,959 and a net result of -€1.2m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 28% of 4652 sector peers (fiscal year 2025). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Wholesale of pharmaceutical and medical goods NACE 46460NACE 47740
1 site
Size
€2.7mtotal assets 2025
- Staff
- 4.1 FTE
- Equity
- €471,959
- Loss
- -€1.2m
Net result -641%: other schema
Structure
- Holdings
- 2
Accounts 38 d early0 of 22 deeds read
Why 53- Loss of €1.2m, the second in a row (FY 2025)- Equity €471,959 (17.3% of total assets)- Liquidity: current ratio 0.56, cash €40,302, halved+ Figures for FY 2025 (filed 23-06-2026)Show the evidence
Checked score
Score 2025
53
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 35% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Weak
Solvency
42+11
equity 17.3% of total assets
Liquidity
6-6
short-term debt 82.7% · cash 1.5%
Profitability
0-14
return on assets -42.5%
Bankruptcy probability, 12 months
1.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.3%lowest value
12-2024: 0.3%▲ +1.2% vs 11-2024
01-2025: 0.3%● 0.0% vs 12-2024
02-2025: 0.3%▲ +2.0% vs 01-2025
03-2025: 0.3%▼ -2.0% vs 02-2025
04-2025: 0.4%▲ +14.0% vs 03-2025
05-2025: 0.5%▲ +27.6% vs 04-2025
06-2025: 0.7%▲ +35.9% vs 05-2025
07-2025: 0.7%▲ +2.5% vs 06-2025
08-2025: 1.4%▲ +105% vs 07-2025
09-2025: 1.4%● 0.0% vs 08-2025
10-2025: 1.4%● 0.0% vs 09-2025
11-2025: 1.4%● 0.0% vs 10-2025
12-2025: 0.9%▼ -35.9% vs 11-2025
01-2026: 0.9%● 0.0% vs 12-2025
02-2026: 0.9%▲ +1.7% vs 01-2026
03-2026: 1.1%▲ +17.6% vs 02-2026
04-2026: 1.1%▲ +3.2% vs 03-2026
05-2026: 1.2%▲ +2.2% vs 04-2026
06-2026: 1.2%▲ +5.3% vs 05-2026
07-2026: 1.9%▲ +59.7% vs 06-2026highest value
08-2026: 1.9%● 0.0% vs 07-2026highest value
09-2026: 1.9%● 0.0% vs 08-2026highest value
10-2026: 1.9%● 0.0% vs 09-2026highest value
- Loss of €1.2m, the second in a row (FY 2025) raises the probability
- Equity €471,959 (17.3% of total assets) raises the probability
- Liquidity: current ratio 0.56, cash €40,302, halved raises the probability
- Figures for FY 2025 (filed 23-06-2026) lowers the probability
Credit up to €25,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity short (current ratio 0.56 against 0.81 in 2024; short-term debt: 82.7% and cash: 1.5% of total assets), and 82.7% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 33%, liquidity 8%, profitability 6%, growth against the median 92%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1919202122232425
2019 to 2025 · latest year €471,959
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
38 d early
2024
1 d early
2023
11 d early
2022
59 d early
2021
30 d early
2020
19 d early
2019
61 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 14 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 1 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
04-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · full…
- Weakest financial yearnet -€1.2m
- Annual accounts filedfiscal year 2024 · abbreviated…
Key points
- Caution: Result fell in 2025different schema filed ▼ 641% View
- Caution: Among the weakest 5% on net resultsector median €40,227 · 4,652 companies -€1.2m View
- Caution: 2 loss-making years in a rowloss fiscal year 2025 -€1.2m View
- Positive: Always filed on timeaccounts within the deadline every year 6 years View
By topic
Network & group
- Subsidiaries
- 2
2 subsidiaries
Timeline
- Events
- 15
- Since
- 2018
- Next accounts
- by 31-07-2027
- 23-06-2026Annual accounts filed
- 31-12-2025Weakest financial year
- 30-07-2025Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Retail sale of medical and orthopaedic goods, excluding…NACE 47741
- Founded
- 23-08-2005
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.